More on KPTI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-2,279.2% Growth)
- Ratings (7.1 Score)

Upcoming Events

- Earnings (5/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Karyopharm Therapeutics (NQ:KPTI)
Delayed: 8.77 -0.05 (0.57%)
Prev. Close $8.82  
Open$8.72 
52 Wk High$19.41 
52 Wk Low$4.83 
Day High$9.11 
Day Low$8.57 
P/E N/A  
EPS$-2.74 
Volume725,196 

Friends, Peers and Foes (?): ALNY, AMGN, LEGN, ARWR, CAPR (more...)

Mar 6, 2026 06:54 AM Karyopharm Therapeutics (KPTI) Reiterated at Overweight by Cantor Fitzgerald
Mar 3, 2026 04:46 PM Form 4 Karyopharm Therapeutics For: Mar 02 Filed by: Abate Kristin
Mar 3, 2026 04:34 PM Form 4 Karyopharm Therapeutics For: Mar 02 Filed by: Cheng Sohanya Roshan
Mar 3, 2026 04:33 PM Form 4 Karyopharm Therapeutics For: Mar 02 Filed by: Mano Michael
Mar 3, 2026 04:30 PM Form 4 Karyopharm Therapeutics For: Mar 02 Filed by: Rangwala Reshma
Mar 3, 2026 04:27 PM Form 4 Karyopharm Therapeutics For: Mar 02 Filed by: Poulton Stuart
Mar 3, 2026 04:27 PM Form 4 Karyopharm Therapeutics For: Mar 02 Filed by: Paulson Richard A.
Mar 3, 2026 06:02 AM Form 8-K Karyopharm Therapeutics For: Feb 27
Mar 2, 2026 04:05 PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 19, 2026 04:06 PM Form 8-K Karyopharm Therapeutics For: Feb 18
View All Articles

Entities mentioned with KPTI

View All Entities